Merck & Co., Inc.

13D and 13G Filings

Issuer	Symbol	CUSIP	% of Class	Shares	Form	Filed
Schedule 13G · 2 securities · passive
Evaxion Biotech A/S 13G/A EVAX · 29970R204	EVAX	29970R204	20.0%	63,004,142	13G/A	2/3/2025 Event 1/31/2025
Merck & Co., Inc.			20.0%	63,004,142
Merck Sharp & Dohme LLC			20.0%	63,004,142
Merck Global Health Innovation Fund, LLC			20.0%	63,004,142
Personalis, Inc. 13G PSNL · 71535D106	PSNL	71535D106	16.5%	14,044,943	13G	12/23/2024 Event 12/19/2024
Merck & Co., Inc.			16.5%	14,044,943
Merck Sharp & Dohme LLC			16.5%	14,044,943

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.